Endo Pharmaceuticals Relocates

Pennsylvania-based Company Moves Its Headquarters to

Support Ongoing Growth and Expansion

Chadds Ford, Pa. – Oct. 31, 2011 –Endo Pharmaceuticals (Nasdaq: ENDP) today announced that it will relocate its corporate headquarters to a new facility based in Malvern, Pa., by December 2012. The move to a new corporate center, located approximately 18 miles from Chadds Ford, is part of Endo’s long-term strategic growth strategy and ongoing transformation into an all-around health solutions company.

With the acquisition of several healthcare, medical device and pharmaceutical companies over the last several years, Endo’s new corporate headquarters addresses its continued growth, and will position Endo closer to the heart of the healthcare corridor in Pennsylvania, where nearly 100 other healthcare and life science companies currently reside.

"This move is an important investment in Endo’s future," says Dave Holveck, CEO of Endo Pharmaceuticals. "I believe this this move will undoubtedly send a positive message of growth, stability and promise to our pharmaceutical and business counterparts."

Endo is committed to a smooth and transparent transition for the Chadds Ford community that helped foster its transformation, and to Malvern, the new community that Endo believes will help sustain its ongoing growth. For more information about the move, visit www.Endo.com.



1 Star2 Stars3 Stars4 Stars5 Stars (No Ratings Yet)

Leave a Reply

You must be logged in to post a comment.